HK1129668A1 - - Google Patents

Info

Publication number
HK1129668A1
HK1129668A1 HK09107754.2A HK09107754A HK1129668A1 HK 1129668 A1 HK1129668 A1 HK 1129668A1 HK 09107754 A HK09107754 A HK 09107754A HK 1129668 A1 HK1129668 A1 HK 1129668A1
Authority
HK
Hong Kong
Prior art keywords
intensity
given
diffractometer
theta
exhibited
Prior art date
Application number
HK09107754.2A
Other languages
English (en)
Inventor
Gerard Coquerel
Loic Lefebvre
Jean-Claude Souvie
Pascale Authouart
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1129668A1 publication Critical patent/HK1129668A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
HK09107754.2A 2006-02-28 2009-08-24 HK1129668A1 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601747A FR2897865B1 (fr) 2006-02-28 2006-02-28 Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
PCT/FR2007/000334 WO2007099216A2 (fr) 2006-02-28 2007-02-26 FORME CRISTALLINE β DU SEL D'ARGININE DU PERINDOPRIL, SON PROCEDE DE PREPARATION, ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT

Publications (1)

Publication Number Publication Date
HK1129668A1 true HK1129668A1 (xx) 2009-12-04

Family

ID=37198804

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09107754.2A HK1129668A1 (xx) 2006-02-28 2009-08-24

Country Status (31)

Country Link
US (1) US7923569B2 (xx)
EP (1) EP2016051B1 (xx)
JP (1) JP5611524B2 (xx)
KR (1) KR20080106947A (xx)
CN (1) CN101389604B (xx)
AT (1) ATE465992T1 (xx)
AU (1) AU2007220434B2 (xx)
BR (1) BRPI0708291B8 (xx)
CA (1) CA2643803C (xx)
CY (1) CY1110082T1 (xx)
DE (1) DE602007006176D1 (xx)
DK (1) DK2016051T3 (xx)
EA (1) EA014715B1 (xx)
ES (1) ES2345291T3 (xx)
FR (1) FR2897865B1 (xx)
GE (1) GEP20135839B (xx)
HK (1) HK1129668A1 (xx)
HR (1) HRP20100357T1 (xx)
MA (1) MA30277B1 (xx)
ME (1) ME01805B (xx)
MX (1) MX2008010747A (xx)
MY (1) MY143557A (xx)
NO (1) NO341238B1 (xx)
NZ (1) NZ570366A (xx)
PL (1) PL2016051T3 (xx)
PT (1) PT2016051E (xx)
RS (1) RS51431B (xx)
SI (1) SI2016051T1 (xx)
UA (1) UA89904C2 (xx)
WO (1) WO2007099216A2 (xx)
ZA (1) ZA200807025B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
AU2013245523C1 (en) * 2008-06-24 2017-09-07 Mylan Laboratories Ltd Novel polymorphic forms of Perindopril (L)-Arginine and process for the preparation thereof
DK2318365T3 (en) * 2008-06-24 2015-11-23 Mylan Lab Ltd NOVEL polymorphic forms of perindopril (L) -arginine AND PROCESS FOR PREPARATION THEREOF
AU2009212902A1 (en) 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
FR2985511B1 (fr) 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2985512B1 (fr) * 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril

Also Published As

Publication number Publication date
NO341238B1 (no) 2017-09-25
EA200801772A1 (ru) 2009-02-27
CA2643803A1 (fr) 2007-09-07
SI2016051T1 (sl) 2010-07-30
NZ570366A (en) 2011-05-27
CN101389604B (zh) 2013-08-21
MA30277B1 (fr) 2009-03-02
US7923569B2 (en) 2011-04-12
CA2643803C (fr) 2017-08-08
MY143557A (en) 2011-05-31
AU2007220434B2 (en) 2010-10-14
CN101389604A (zh) 2009-03-18
RS51431B (en) 2011-04-30
PL2016051T3 (pl) 2010-08-31
WO2007099216A3 (fr) 2007-10-25
GEP20135839B (en) 2013-06-10
BRPI0708291B1 (pt) 2021-02-02
EP2016051A2 (fr) 2009-01-21
HRP20100357T1 (hr) 2010-07-31
KR20080106947A (ko) 2008-12-09
WO2007099216A2 (fr) 2007-09-07
ZA200807025B (en) 2009-11-25
NO20083506L (no) 2008-08-13
JP5611524B2 (ja) 2014-10-22
BRPI0708291A2 (pt) 2011-05-24
US20090186934A1 (en) 2009-07-23
AU2007220434A1 (en) 2007-09-07
ME01805B (me) 2011-04-30
FR2897865A1 (fr) 2007-08-31
MX2008010747A (es) 2008-09-01
UA89904C2 (ru) 2010-03-10
CY1110082T1 (el) 2015-01-14
DE602007006176D1 (de) 2010-06-10
JP2009529500A (ja) 2009-08-20
PT2016051E (pt) 2010-05-13
FR2897865B1 (fr) 2008-04-18
BRPI0708291B8 (pt) 2021-05-25
DK2016051T3 (da) 2010-08-09
EP2016051B1 (fr) 2010-04-28
ES2345291T3 (es) 2010-09-20
EA014715B1 (ru) 2011-02-28
ATE465992T1 (de) 2010-05-15

Similar Documents

Publication Publication Date Title
HK1129668A1 (xx)
TW200736199A (en) New crystalline form V of agomelatine, a process for its preparation and pharmaceutical compositions containing it
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
AR034124A1 (es) Forma cristalina alfa de la sal de terbutilamina de perindopril, procedimiento para su preparacion y composiciones farmaceuticas que la contienen
PL2185510T3 (pl) Nowe sole bazedoksyfenu
MX2008010481A (es) Compuestos que tienen afinado para el receptor f-ht6.
UA83718C2 (ru) Кристаллическая форма iv агомелатина, способ ее получения и фармацевтическая композиция, которая ее содержит
PH12015502825B1 (en) Crystals
ES2613716T3 (es) Formas cristalinas de un derivado de purina
RS20090104A (xx) Jedinjenja pirido (2,3-d) pirimidinona i njihova upotreba kao inhibitora p13
CO5700731A2 (es) Polimorfos cristalinos de un ligando receptor de cxc-quimiocina
UA93531C2 (xx) Новий гідросульфат$новый гидросульфат
NO20064212L (no) Piperidinyl som retter seg mot forbindelser som selektivt binder integriner
GEP20125433B (en) α CRYSTALLINE FORM OF THE ARGININE SALT OF PERINDOPRIL, PROCESS FOR PREPARING IT, AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT
MX2009003257A (es) Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
MY147188A (en) Substituted imidazole compounds as ksp inhibitors
RS53057B (en) NEW CRYSTAL FORM 3- (difluoromethyl) -1-methyl-N- (3`, 4`, 5`-trifluoro [1,1`-biphenyl] -2-yl) -1H-pyrazole-4-carboxamide
IL189883A0 (en) Isoquinolines as igf-1r inhibitors
TW200724642A (en) Metal salts of quinolinols and quinolinol derivatives as adhesion and conductivity promoters in die attach adhesives
MD20120130A2 (en) Delta crystalline form of the L-arginine salt of perindopril, a process for its preparation and pharmaceutical compositions containing it
TW200616624A (en) 2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
TW200509906A (en) Crystalline 1-methylcarbapenem compounds
WO2008081104A3 (fr) Conglomerats de sels de potassium du tenatoprazole